FIELD: medicine; endocrinology.
SUBSTANCE: derivatives of cyanopyrolidines, characterised by the structural formula I, pharmaceutical compositions on their basis or their combination with other hypolipidemic agents are administered in effective doses for lipidemia treatment.
EFFECT: effective correction of lipidemia at the expense of appreciable depression of levels of triglycerides, cholesterol, and low density lipoproteins.
1 ex, 14 cl
